A new study has found that combining ibrutinib and rituximab could help cancer patients with chronic lymphocytic leukemia (CLL). The results of the study were presented this week at the 54th annual meeting of the American Society of Hematology (ASH).…
Cancer Drug Erbitux Fails to Produce Results in Trials
The cancer drug Erbitux, which is manufactured by Merck & Co., Inc, has failed to produce any significant new results for the second month in a row. The German pharmaceutical company, one of the largest in the world, watched helplessly…